Advanced Search

Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2015 December;81(12) > Minerva Anestesiologica 2015 December;81(12):1377-83

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036

Frequency: Monthly

ISSN 0375-9393

Online ISSN 1827-1596

 

Minerva Anestesiologica 2015 December;81(12):1377-83

    EXPERT OPINION

Vasopressin in cirrhosis and sepsis: physiology and clinical implications

Wagener G. 1, Bakker J. 2, 3

1 Department of Anesthesiology, College of Physicians and Surgeons of Columbia University New York, New York, NY, USA;
2 Department of Intensive Care Adults, Erasmus MC University Medical Center, Rotterdam, The Netherlands;
3 Department of Pulmonology, Allergy and Critical Care, College of Physicians and Surgeons of Columbia University New York, New York, NY, USA

Arginine-vasopressin (AVP) is an important hormone in the regulation of plasma osmolality and blood volume/pressure. In clinical practice it is frequently used in the treatment of septic shock and decompensated cirrhosis. In this review the physiology of AVP and its analogues is presented. In addition the use of AVP in cirrhosis and sepsis is reviewed.

language: English


FULL TEXT  REPRINTS

top of page